Jane Papadaki Email

VP Market Development & Commercial Operations . Immunexpress

Current Roles

Employees:
20
Revenue:
$3.1M
About
Immunexpress is a privately owned company creating revolutionary molecular diagnostics for sepsis. The company has offices in Seattle, USA and Brisbane, Australia. Immunexpress's product pipeline aims to address the overwhelming unmet clinical needs of sepsis patients, as well as clinicians, payers and healthcare systems. Unlike the traditional approach to sepsis diagnosis, SeptiCyte® quantifies the specific molecular biomarkers from a patient's immune system ('host response'). Biomarkers capture signals from a patient's immune system in response to infection. These biomarkers may hold the key to early detection of sepsis, as well as guiding the use and timing of drugs and other therapies.
Immunexpress Address
425 Pontius Ave N
Seattle, WA
United States
Immunexpress Email

Past Companies

Immunexpress Inc.VP of Market Development & Commercial Operations
Takara Bio USAAssoc. Sales Director, Automation
WafergenGeneral Manager/Managing Director EMEA

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.